Abbott Partners With Operation Smile to Support 40 Medical Missions in 25 Countries

AbbottAbbott (NYSE: ABT) is supporting Operation Smile's global initiative to help bring smiles to kids with facial deformities by providing treatment to an estimated 5,000 children in need of surgeries. The initiative, which is part of Operation Smile's 25th anniversary celebration - World Journey of Smiles - takes place this month and consists of 40 medical missions across 25 countries. Abbott has donated 1,700 bottles of its anesthesia product, valued at almost $500,000, for the surgeries.

"Abbott has supported Operation Smile for many years, and once again is providing critical support as we work to transform the lives of children through our World Journey of Smiles initiative," said Bill Magee, M.D., Co-founder and CEO of Operation Smile. "We are proud to be their partner in improving the health of children and adults around the world."

Since 1993, Abbott and Abbott Fund have donated more than $3 million in grants and products to support Operation Smile medical missions, helping treat more than 20,000 patients worldwide. In 2005, Abbott Fund expanded its partnership with Operation Smile to help build sustainable health care capacity in developing countries, including strengthening the expertise of pediatricians and anesthesiologists to provide emergency critical care. To date, Abbott Fund and Operation Smile have trained more than 1,600 health workers in nine developing countries.

"Abbott is proud to help Operation Smile accomplish its 25th anniversary goal of bringing smiles and hope to an estimated 5,000 children in 25 countries," said Kathy Pickus, director, Global Citizenship and Policy, Abbott. "Through ongoing medical missions and programs to train health workers, we look forward to continuing our partnership to make an enduring contribution to improving people's lives."

About Operation Smile
Founded in 1982, Operation Smile, headquartered in Norfolk, Virginia, is a worldwide children's medical charity whose network of global volunteers are dedicated to helping improve the health and lives of children and young adults. Since its founding, Operation Smile has treated more than 100,000 children born with cleft lips, cleft palates and other facial deformities. In addition to contributing free medical treatment, Operation Smile trains local medical professionals in its 25 partner countries and leaves behind crucial equipment to lay the groundwork for long-term self-sufficiency. For more information, visit www.operationsmile.org.

About Abbott and Abbott Fund
In 2006, Abbott and Abbott Fund provided nearly $300 million in grants and product donations to improve the lives of millions of people worldwide, including supporting medical missions and other global humanitarian efforts in more than 98 countries.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacturing and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries. Abbott's news releases and other information are available on the company's Web site at www.abbott.com.

Abbott Fund is a philanthropic foundation established by Abbott in 1951. Abbott Fund's mission is to create healthier global communities by investing in creative ideas that promote science, expand access to health care and strengthen communities worldwide. For more information on Abbott Fund, visit www.abbottfund.org.

Most Popular Now

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

Time-restricted eating reshapes gene expression th…

Numerous studies have shown health benefits of time-restricted eating including increase in life span in laboratory studies, making practices like intermittent fasting a ...

Incurable liver disease may prove curable

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the li...

Scientists develop a cancer vaccine to simultaneou…

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s ...

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...

500,000 missed out on blood pressure lowering drug…

Nearly half a million people missed out on starting medication to lower their blood pressure during the COVID-19 pandemic, according to research supported by the British ...